These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21918925)

  • 1. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus.
    Leslie DB; Dorman RB; Serrot FJ; Swan TW; Kellogg TA; Torres-Villalobos G; Buchwald H; Slusarek BM; Sampson BK; Bantle JP; Ikramuddin S
    Obes Surg; 2012 Mar; 22(3):367-74. PubMed ID: 21918925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m
    Ling J; Tang H; Meng H; Wu L; Zhu L; Zhu S
    J Endocrinol Invest; 2022 Sep; 45(9):1729-1740. PubMed ID: 35596918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.
    Serrot FJ; Dorman RB; Miller CJ; Slusarek B; Sampson B; Sick BT; Leslie DB; Buchwald H; Ikramuddin S
    Surgery; 2011 Oct; 150(4):684-91. PubMed ID: 22000180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
    Feng W; Yin T; Chu X; Shan X; Jiang C; Wang Y; Qian Y; Zhu D; Sun X; Bi Y
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3138. PubMed ID: 30740871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study.
    Carlsson ER; Allin KH; Madsbad S; Fenger M
    Lipids Health Dis; 2019 Sep; 18(1):169. PubMed ID: 31488158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years.
    Sepúlveda M; Alamo M; Preiss Y; Valderas JP
    Obes Surg; 2018 Nov; 28(11):3466-3473. PubMed ID: 30069859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Inadequate Weight Loss After Roux-en-Y Gastric Bypass Is not Associated with Poor Cardiovascular or Metabolic Outcomes: Experience from a Single Institution.
    Haskins IN; Corcelles R; Froylich D; Boules M; Hag A; Burguera B; Schauer PR; Kroh M; Brethauer SA
    Obes Surg; 2017 Mar; 27(3):676-680. PubMed ID: 27510588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
    Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
    Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
    Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
    Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes.
    Tangalakis LL; Tabone L; Spagnoli A; Muehlbauer M; Omotosho P; Torquati A
    Obes Surg; 2020 Jan; 30(1):290-295. PubMed ID: 31471767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
    Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
    BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m
    Cheng A; Yeoh E; Moh A; Low S; Tan CH; Lam B; Sum CF; Subramaniam T; Lim SC
    Diabetes Res Clin Pract; 2022 Jun; 188():109900. PubMed ID: 35513159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.
    Dorman RB; Serrot FJ; Miller CJ; Slusarek BM; Sampson BK; Buchwald H; Leslie DB; Bantle JP; Ikramuddin S
    Ann Surg; 2012 Feb; 255(2):287-93. PubMed ID: 21975321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y gastric bypass in Chinese obese patients with BMI 28-35 kg/m² and type 2 diabetes: a 6-month follow-up.
    Tu Y; Yu H; Bao Y; Zhang P; Di J; Han X; Jia W
    BMC Endocr Disord; 2015 Jun; 15():26. PubMed ID: 26054757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
    Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
    Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
    Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.